Spots Global Cancer Trial Database for intensity modulated radiation therapy
Every month we try and update this database with for intensity modulated radiation therapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery | NCT04316039 | Low-grade Gliom... | Temozolomide intensity modul... | 18 Years - 70 Years | West China Hospital | |
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer | NCT03067610 | Head and Neck C... Carcinoma, Squa... Neoplasms, Oral Neoplasms, Phar... | Intensity Modul... chemotherapy | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery | NCT04316039 | Low-grade Gliom... | Temozolomide intensity modul... | 18 Years - 70 Years | West China Hospital | |
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma | NCT02296684 | Cancer of Head ... Head and Neck C... Neoplasms, Head... Carcinoma, Squa... Squamous Cell C... Squamous Cell C... | MK-3475 (neoadj... Surgery Intensity modul... Image-guided ra... Cisplatin MK-3475 (adjuva... Peripheral bloo... | 18 Years - | Washington University School of Medicine | |
Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer | NCT01576939 | Head and Neck C... | Intensity Modul... | 18 Years - | Stanford University | |
Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer | NCT01576939 | Head and Neck C... | Intensity Modul... | 18 Years - | Stanford University | |
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC | NCT05941741 | Nasopharyngeal ... Immune Checkpoi... Radiotherapy Chemotherapy | Intensity Modul... Chemotherapy Immune checkpoi... Low-dose radiot... | 18 Years - 70 Years | Sun Yat-sen University | |
Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT00652613 | Squamous Cell C... | 3 Dimensional R... Intensity Modul... | 18 Years - 65 Years | Tata Memorial Hospital | |
Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients | NCT03387774 | Oral Mucositis ... | Cisplatin Intensity Modul... Ulinastatin | 18 Years - 65 Years | Sun Yat-sen University | |
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | NCT03910634 | Esophageal Canc... Radiotherapy Si... | Fluorouracil Intensity modul... carboplatin | 65 Years - 85 Years | Sun Yat-sen University | |
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | NCT01566435 | Head and Neck N... | paclitaxel albu... Cisplatin Fluorouracil Intensity modul... Cetuximab Quality-of-life... | 18 Years - | Washington University School of Medicine | |
Hypofractionated Radiation Therapy in Prostate Cancer | NCT01764646 | Malignant Neopl... Local Disease | Intensity modul... Volumetric modu... Image guided ra... | 18 Years - 85 Years | University Hospital, Geneva | |
Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer | NCT01617980 | Non-small Cell ... | Multimodal hypo... | 18 Years - | German Cancer Research Center | |
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer | NCT02555644 | Head and Neck N... | Prexasertib Cisplatin Cetuximab Intensity Modul... | 18 Years - | Eli Lilly and Company | |
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | NCT03910634 | Esophageal Canc... Radiotherapy Si... | Fluorouracil Intensity modul... carboplatin | 65 Years - 85 Years | Sun Yat-sen University | |
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer | NCT00057785 | Head and Neck C... Oral Complicati... Radiation Toxic... | cisplatin fluorouracil Intensity modul... | 18 Years - | Radiation Therapy Oncology Group | |
Adaptive Radiotherapy for Head and Neck Cancer | NCT03096808 | Head and Neck C... Paranasal Sinus... Oropharynx Canc... Oral Cavity Can... Nasopharynx Can... Larynx Cancer Hypopharynx Can... | Adaptive Radiot... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) | NCT05371132 | Metastatic Mali... Lymphoma | Positron Emissi... Stereotactic Bo... Zirconium Zr 89... Intensity Modul... | 18 Years - | City of Hope Medical Center | |
Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients | NCT03839602 | Target Volume D... Early-stage Nas... Intensity Modul... | Reducing CTV | 18 Years - 70 Years | Sun Yat-sen University | |
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | NCT02145390 | Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive... | Transurethral R... Intensity Modul... Expanded Prosta... International P... | 18 Years - | University of Miami | |
IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer | NCT03258671 | Non-Small Cell ... Nonsmall Cell L... Carcinoma, Non-... | EGFR-TK Inhibit... Intensity Modul... | 18 Years - 80 Years | Guizhou Medical University | |
Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma | NCT05653622 | Glioblastoma Mu... | Integrated boos... | 18 Years - | Institut de cancérologie Strasbourg Europe | |
Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma | NCT04823468 | Nasopharyngeal ... Nutritional Sup... | Abbott®Ensure Intensity Modul... cisplatin | 18 Years - 70 Years | First Affiliated Hospital of Fujian Medical University | |
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery | NCT04316039 | Low-grade Gliom... | Temozolomide intensity modul... | 18 Years - 70 Years | West China Hospital | |
Hypofractionated Radiation Therapy in Prostate Cancer | NCT01764646 | Malignant Neopl... Local Disease | Intensity modul... Volumetric modu... Image guided ra... | 18 Years - 85 Years | University Hospital, Geneva | |
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer | NCT02555644 | Head and Neck N... | Prexasertib Cisplatin Cetuximab Intensity Modul... | 18 Years - | Eli Lilly and Company | |
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy | NCT02145390 | Bladder Cancer Bladder Carcino... Transition Cell... Muscle Invasive... | Transurethral R... Intensity Modul... Expanded Prosta... International P... | 18 Years - | University of Miami | |
Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases | NCT00328575 | Neoplasm Metast... | Intensity-Modul... | 18 Years - | Thomas Jefferson University | |
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | NCT02678520 | Prostate Cancer | 3-D Conformal R... Intensity Modul... Casodex, Zolade... | 18 Years - | University of Kansas Medical Center | |
Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab | NCT01312493 | Head and Neck C... | Panitumumab Intensity Modul... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy | NCT01808677 | Non-Small Cell ... | Thoracic Reirra... | 18 Years - | M.D. Anderson Cancer Center | |
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer | NCT04386993 | Endometrial Can... | Intensity modul... | 18 Years - | Washington University School of Medicine | |
A Study for Short Preoperative Chemoradiotherapy for Resectable Rectal Carcinoma | NCT00973778 | Chemoradiothera... | Preoperative Ch... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma | NCT04823468 | Nasopharyngeal ... Nutritional Sup... | Abbott®Ensure Intensity Modul... cisplatin | 18 Years - 70 Years | First Affiliated Hospital of Fujian Medical University | |
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer | NCT04046575 | Esophagus Cance... Esophageal Canc... Cancer of the E... | Intensity Modul... Carboplatin MD Anderson Sym... EuroQol (EQ-5D) SF-12 MOS Social Supp... CES-D Blood for ctDNA... Blood for SCCA Paclitaxel | 18 Years - | Washington University School of Medicine | |
Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer | NCT00858663 | Head and Neck C... | intensity modul... RAD001 (everoli... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer | NCT01908478 | Pancreatic Canc... | Veliparib Gemcitabine Intensity modul... | 18 Years - | Cedars-Sinai Medical Center | |
Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer | NCT03300765 | Thyroid Cancer | Apatinib Intensity modul... | 18 Years - 80 Years | Fudan University | |
Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer | NCT01617980 | Non-small Cell ... | Multimodal hypo... | 18 Years - | German Cancer Research Center | |
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer | NCT00057785 | Head and Neck C... Oral Complicati... Radiation Toxic... | cisplatin fluorouracil Intensity modul... | 18 Years - | Radiation Therapy Oncology Group | |
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma | NCT04124198 | Oropharynx Canc... Oropharynx Squa... Carcinoma, Squa... Carcinoma Oropharyngeal N... Neoplasms, Squa... Neoplasms, Glan... Neoplasms by Hi... Pharyngeal Neop... Otorhinolaryngo... Head and Neck N... Neoplasms by Si... Otorhinolaryngo... Pharyngeal Dise... Papillomavirus ... Virus Diseases DNA Virus Infec... Tumor Virus Inf... Quality of Life | Intensity-Modul... Cisplatin Nimorazole. Transoral Robot... | 18 Years - | Rigshospitalet, Denmark | |
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer | NCT01617161 | Prostate Cancer | Proton Beam The... Intensity Modul... | 18 Years - | Massachusetts General Hospital | |
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer | NCT01617161 | Prostate Cancer | Proton Beam The... Intensity Modul... | 18 Years - | Massachusetts General Hospital | |
Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma; | NCT01745107 | Esophageal Neop... Esophageal Canc... Esophageal Canc... Esophageal Canc... Esophageal Canc... | Prophylactic po... | 40 Years - 72 Years | ChineseAMS | |
Intensity Modulated Radiation Therapy for Head and Neck Cancer | NCT00188877 | Nasopharyngeal ... | intensity modul... cisplatinium an... | 18 Years - 70 Years | University Health Network, Toronto | |
Functional Outcomes Following Anal Cancer Treatment | NCT01853059 | Anal Cancer | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | ||
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial | NCT03082846 | Glioma Radiotherapy, I... Maximum Tolerat... | hypofractionate... Temozolomide ch... | 18 Years - 70 Years | The Second Hospital of Hebei Medical University | |
SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC | NCT02738723 | Small Cell Lung... | SBRT IMRT EP | 18 Years - 70 Years | Third Military Medical University | |
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin | NCT02609503 | Head and Neck C... | Pembrolizumab Intensity Modul... | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. | NCT01732640 | Squamous Cell C... | Afatinib Paclitaxel Carboplatin Cisplatin Intensity Modul... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma | NCT04124198 | Oropharynx Canc... Oropharynx Squa... Carcinoma, Squa... Carcinoma Oropharyngeal N... Neoplasms, Squa... Neoplasms, Glan... Neoplasms by Hi... Pharyngeal Neop... Otorhinolaryngo... Head and Neck N... Neoplasms by Si... Otorhinolaryngo... Pharyngeal Dise... Papillomavirus ... Virus Diseases DNA Virus Infec... Tumor Virus Inf... Quality of Life | Intensity-Modul... Cisplatin Nimorazole. Transoral Robot... | 18 Years - | Rigshospitalet, Denmark | |
Chronomodulated Chemotherapy Followed by Concurrent Chemo-radiotherapy With IMRT in the Treatment of Advanced Nasopharyngeal Cancer | NCT02937519 | Esophageal Neop... | Chrono-chemothe... Routine intrave... induction Chron... induction Routi... cisplatin chron... cisplatin routi... intensity-modul... | 18 Years - 70 Years | Guiyang Medical University | |
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer | NCT01148056 | Rectal Cancer | Intensity Modul... | 18 Years - | Massachusetts General Hospital | |
IMRT Lower Limb Soft Tissue Sarcoma | NCT00188175 | Sarcoma | Intensity Modul... | 16 Years - | University Health Network, Toronto | |
A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer | NCT00490282 | Head and Neck C... Oropharyngeal C... | Intensity Modul... Adaptive Radiot... | 18 Years - | M.D. Anderson Cancer Center | |
A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. | NCT01732640 | Squamous Cell C... | Afatinib Paclitaxel Carboplatin Cisplatin Intensity Modul... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | NCT00513383 | Squamous Cell C... | Panitumumab Carboplatin Paclitaxel Intensity Modul... 5-Fluorouracil Docetaxel Cisplatin | 18 Years - | Massachusetts General Hospital | |
3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy | NCT00520702 | Lung Cancer | Intensity Modul... 3-Dimensional C... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition | NCT04436965 | Nasopharyngeal ... Nutrition Thera... | Standardized nu... Cisplatin Intensity Modul... | 18 Years - 65 Years | Sun Yat-sen University | |
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin | NCT02609503 | Head and Neck C... | Pembrolizumab Intensity Modul... | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
Phase II Trial Evaluating Elimination of Radiation Therapy | NCT00593840 | Cancer of the L... | Intensity modul... | 18 Years - | Washington University School of Medicine | |
Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma | NCT04823468 | Nasopharyngeal ... Nutritional Sup... | Abbott®Ensure Intensity Modul... cisplatin | 18 Years - 70 Years | First Affiliated Hospital of Fujian Medical University | |
Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases | NCT00328575 | Neoplasm Metast... | Intensity-Modul... | 18 Years - | Thomas Jefferson University | |
Phase II Trial Evaluating Elimination of Radiation Therapy | NCT00593840 | Cancer of the L... | Intensity modul... | 18 Years - | Washington University School of Medicine |